Back to trial detailsIntake questionnaire
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Applying to Texas Oncology - San Antonio · San Antonio, Texas
This location is no longer enrolling.
Other locations for this study may still be open.
Pick another location